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Copyright © 200? JCBN Summary In the trend of biological science after the completion of the human genome project,
appreciation of an organism as a system rather than the sum of many molecular functions is
necessary. On the investigation of DNA damage and repair, therefore, the orientation toward
systematic and comprehensive genome-scale approaches is rapidly growing. The immuno-
precipitation-based technique combined with high-density microarrays is one of the promising
methods to provide access to such novel research strategies. We propose this sort of research
area as oxygenomics.
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Introduction
In the current context of life science, integrative analyses,
such as diverse ‘omics’ analyses, have been actively
conducted with an aim to comprehend organisms as a whole.
A rapid paradigm shift from the molecule to the system has
been taking place over the whole area of biological science.
The fact that a draft sequence of the whole human genome
was published in 2001 [1, 2] has not simply meant that all of
the sequence information of DNA, including human genes,
was acquired. That was a revolutionary achievement in
biological science, which enabled the information of the
whole human genome to be handled as finite data in a
computer. Consequently, genomics has forced biologists to
reform their fundamental attitude when developing strategies
for new studies of life science. Hereafter, we need to
elucidate functions of the genome and systematic and
comprehensive genome-wide approaches are becoming
more required. Before this transition took place, biological
research generally focused on one gene or one pathway at a
time, but in the current circumstances, we need to appreciate
an organism as a system in a genome-scale, taking the
genome database into account. Based on this trend, in this
review, we present an overview of the systematic and
comprehensive genome-scale approaches to investigate the
dynamics of DNA damage and repair with a primary focus
on newly developed experimental technologies.
Genome-Scale Views of DNA Damage
Little information has been acquired about the distribution
of DNA damage over the whole genome. The information of
the genome, unlike the transcriptome or proteome, essentially
does not change in the life of an organism and shows high
similarity between individuals in a species. Indeed, cells
regard the maintenance of the stability of genome informa-
tion as a mission of the highest priority. Because it threatens
genomic integrity, DNA damage induced by various causative
factors must be processed immediately. Viewing this process
on a genomic scale raises a new important question. It is
the problem of how each kind of DNA damage is distributed
throughout a genome. For example, when studying the
pathogenesis of cancer, information on the frequency of
DNA damage at each genomic site is extremely valuable. At
present, however, we can find very few studies that analyzed
the frequency of generation, accumulation or repair of DNA
damage across every genomic region.S. Akatsuka and S. Toyokuni
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It is important to map various kinds of damage in different
types of cells under various physiological and pathological
conditions. The term genomic damage includes many sorts
of chemical changes of DNA molecules (e.g. oxidative
modification of bases, formation of bulky DNA-adducts,
single or double strand breaks, etc.). Different types of
damage are produced through different processes and have
different influences on the cell. Therefore, each type of
damage is of particular importance in biology and medicine.
In addition, it is thought that distribution of these forms of
DNA damage may vary depending on the cell type and on
the conditions under which the cells are placed.
A powerful experimental method to deal with this
problem is based on immunoprecipitation technique. The
basic idea of the method is that, after fragmentation of
genomic DNA extracted from a specimen, we can isolate
only the fragments bearing a marker of specific DNA
damage by applying the principle of immunoprecipitation.
There are two variations of immunoprecipitation for this
purpose that differ in the sort of antigen to which the adopted
antibody binds. The first one, DNA immunoprecipitation
(DnaIP), uses antibodies that recognize DNA damage
itself (Fig. 1). We recently analyzed the distributions of
8-oxoguanine and acrolein-modified adenine residues
(acrolein-dA) on the whole genome by cloning and mapping
the fragments obtained through DnaIP [3]. In another appli-
cation, the genomic fragments adducted with benzo(a)pyrene
diol epoxides collected in the same way were cloned [4].
The other immunoprecipitation-based method is the example
of chromatin immunoprecipitation, which uses antibodies
against the proteins associated with DNA damage and repair.
Armed with these immunopreciptation-based methods, one
can obtain the sample for mapping the sites at which
particular genomic damage is generated or processed.
Approaches Based on Microarray Technology
DNA microarray is first on the list of the novel techno-
logies that have made a great advance in the post-genome
sequence era. The improvement in coverage and accuracy
of the major genomic databases and the development of
manufacturing technologies and analysis tools has supported
the growth of this technology. Although it had been used to
analyze transcriptomes in the early years, microarrays can
now carry as many probes as can represent an entire genome
on one chip, providing high-density views of genetic states.
Thanks to the high capacity attained, the use of microarrays
has expanded from gene expression profiling to include a
variety of applications, such as array-based comparative
genomic hybridization (CGH) [5], alternate transcripts [6]
and microRNA [7] profiling, epigenomic analyses [8] and
germline genotyping [9].
There have been two types of microarrays, which are
made in different ways. One uses PCR products derived
from genomic or cDNA clones as probes to detect targets.
The prepared DNA for each probe is spotted on individual
sections on the surface of a glass slide [10]. For the other
type, an array of oligonucleotide probes is chemically
synthesized on the chip itself [11]. In the early years, spotted
microarrays were intensively used because of the cost
advantage and the flexibility for customization. However, as
the spotted array has a problem in specificity of hybridiza-
tion, the oligonucleotide microarray, to which high-quality
analyses can be applied, is generally used today.
The immunoprecipitation-based methods explained above
can become more powerful tools when combined with
microarray technology. The combination of the immuno-
precipitation-based techniques and high-density microarrays
covering a genome totally, such as a genome chip, enables
us to take a snapshot of the dynamics of various genomic
activities in full size.
If based on DnaIP, the DNA fragments collected using the
antibody capable of catching chemically altered DNA are
Fig. 1. Principle of DNA immunoprecipitation (DnaIP) method
to analyze damaged genomic regions.Oxygenomics
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applied to a genome chip, which reveals the distribution of
the DNA modification throughout the genome in a single
experiment. Recently, systems of array-based CGH for
genomic analysis of cancer have been widely used in many
laboratories. Those platforms provided by life science
companies generally include the application software to
analyze a vast amount of data generated from the result of
the microarray experiment, which permits making full use
of advanced information technologies to interpret the
experimental output [12, 13]. Thus far, an analysis of the
methylation state of CpG islands was performed with this
method [14]. We have not seen any publication of the
example where this method was applied to DNA damage
yet, but it will certainly appear pretty soon.
The system that applies the products of chromatin immuno-
precipitation (ChIP) to the microarray (= DNA chip) is
already named “ChIP-chip” or “ChIP-on-chip” [15–17].
In short, chromatin immunoprecipitation is the method to
isolate, using specific antibodies, chromatin fragments that
are bound by a particular nuclear protein or associated with
a particular histone-modification signature [18, 19] (Fig. 2).
The ChIP-chip method has the potential to disclose the
patterns of distribution on the genome of many kinds of
DNA-binding proteins or histone-modifications in a single
assay. The ChIP-chip technique is rapidly spreading as a tool
to analyze the molecular phenomena involved in the control
of various functions of the genome, such as transcriptional
regulation or DNA replication and repair [20–23]. Also
regarding the analysis of DNA damage, genome-scale
assays with the ChIP-chip technique have been carried out
by utilizing antibodies against the associated proteins that
are recruited to the damaged site in the genome or the
histone that received chemical modification. Employing an
antibody against phosphorylated H2AX, a histone variant
that aggregates at the DNA ends generated by double strand
breaks, the distribution of the damage was analyzed in
senescent human cells [24].
Approaches Based on Cytological Methodology
The achievements of the genome projects of major model
organisms have, no doubt, defined a new paradigm in 21st
century biology. Knowledge of the genome sequence has
certainly expedited the search for genes responsible for
specific medical disorders, simplified the search for homo-
logues of genes among the species sequenced and allowed
us to predict likely gene units that used to be unknown.
Sequence information alone, however, is not always
sufficient to predict how frequently a gene is transcribed,
how the frequency varies depending on the cell type and
what function the gene product might perform, because the
extremely complex gene expression pathways found in
mammalian cells are regulated at multiple different levels.
While DNA-binding proteins and their interactions with
the initiation complex drive transcription, it is now clear
that the efficiency and the selectivity of this process are
strongly influenced by higher nuclear organization [25].
Spatial organization of genomes also influences DNA
replication and repair in mammalian cells [26, 27]. Thus,
the study of the spatial architecture within the eukaryotic
nucleus is of greater importance in the post-genome
sequence era.
Recently, technologies to visualize chromosomes and
other nuclear structures, especially during interphase, under
a microscope are growing rapidly. This owes mainly to the
development of the fluorescence imaging technique and the
improvement of the quality of genome databases. Chromo-
somes in mitosis or meiosis and during interphase can be
visualized by the application of fluorescence in situ hybrid-
ization (FISH) [28, 29], whereas the spatial localization of
the proteins involved in transcription, replication or repair
and the modification of histones can be detected using
fluorescence immunocytochemistry [30]. Further, experi-
Fig. 2. Principle of chromatin immunoprecipitation (ChIP)
method.S. Akatsuka and S. Toyokuni
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mental systems to monitor the motion of these nuclear
components in a living cell along the time axis are now
being developed, making use of fluorescently conjugated
proteins microinjected into the cell or constructs fused
with a fluorescent protein transfected into the cell [31].
There have also been recent studies that analyzed the
distribution of the marker relevant to DNA damage using
traditional cytogenetical methods with metaphase spreads.
Ohno  et al. [ 32] detected 8-oxoguanine residues on
metaphase chromosomes of human lymphocytes by applying
fluorescent immunostaining. On the other hand, Surrallés
et al. [33] combined FISH on metaphase spreads with the
immunoprecipitation-based isolation procedure. In order to
elucidate the site-specificity of nucleotide excision repair
(NER), they labeled the genomic sites where unscheduled
DNA synthesis had occurred after UV irradiation with 5-
bromodeoxyuridines (BrdUrd) in human fibroblasts deficient
in NER, collected the fragments containing BrdUrd-labeled
repair patches after DNA extraction and hybridized the
fluorescent DNA probes prepared from the collected
fragments to the metaphase chromosomes.
Recently, the concept of chromosome territory (CT) has
been established [34, 35]. This concept indicates that each
chromosome occupies a spatially limited volume in the
nucleus, even at interphase. The arrangement of CTs appears
to be different among different types of cells [36]. It is
possible that the genome areas susceptible to oxidative
damage may differ depending on the spatial organization of
the genome in each cell. Accordingly, we decided to explore
the relationship between the distribution of the oxidative
DNA damage on the genome we detected and the arrange-
ment of CTs in biologically identical cells. Interestingly,
we found that a chromosome on which 8-oxoguanines were
detected very frequently concentrated at the center of the
nucleus, whereas a chromosome with a high incidence of
acrolein-dA was located toward the nuclear envelope in
the result of chromosome painting, i.e. FISH with the probe
representing a whole chromosome, against interphase cells
[3]. This may be explained by the fact that acrolein, an
aldehyde, comes from the cytoplasm or directly from the
nuclear membrane (Fig. 3). We propose this sort of research
area as “oxygenomics”.
Concluding Remarks
This is the post-genome sequence era, given the comple-
tion of genome projects of humans, mice, rats and other
species. The sequence information in public databases is a
great advantage for researchers of oxidative DNA damage
who are aiming for genome-scale approaches. Furthermore,
current advances in microarray technologies for high-
resolution analyses and visualization technologies for in situ
detection promise to provide them with clear and detailed
views of genome dynamics involved in DNA damage and
repair.
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